1. Home
  2. SITM vs ARWR Comparison

SITM vs ARWR Comparison

Compare SITM & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiTime Corporation

SITM

SiTime Corporation

HOLD

Current Price

$330.20

Market Cap

9.7B

Sector

Technology

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$63.61

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SITM
ARWR
Founded
2003
2003
Country
United States
United States
Employees
395
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.6B
IPO Year
2019
1993

Fundamental Metrics

Financial Performance
Metric
SITM
ARWR
Price
$330.20
$63.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
10
Target Price
$325.63
$63.70
AVG Volume (30 Days)
330.0K
2.2M
Earning Date
02-04-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$281,486,000.00
$829,448,000.00
Revenue This Year
$58.61
N/A
Revenue Next Year
$39.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
59.04
23258.15
52 Week Low
$105.40
$9.57
52 Week High
$387.52
$72.36

Technical Indicators

Market Signals
Indicator
SITM
ARWR
Relative Strength Index (RSI) 44.12 50.93
Support Level $352.42 $65.94
Resistance Level $382.72 $69.71
Average True Range (ATR) 18.04 3.43
MACD -5.55 -1.40
Stochastic Oscillator 3.43 32.66

Price Performance

Historical Comparison
SITM
ARWR

About SITM SiTime Corporation

SiTime Corp is a provider of silicon timing systems solutions. The company designs develops and sell silicon timing systems solutions for different industries including automotive, infrastructure, aerospace-defense, consumer, internet of things, consumer and industrials. Its product offerings include Stratum 3E DCOCXOs, Programmable OCXOs, MHz Oscillators, 32.768 kHz Oscillators, Embedded Resonators, Precision MHz Super-TCXOs, and Ruggedized Oscillators. It sells its products around Taiwan, Hong Kong, the United States, and other regions and generates the majority of its revenue from Taiwan.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

Share on Social Networks: